HIKARI Laboratories
Anti-aging Solutions for Cosmetic Applications
Company Overview
Snapshot
Founded in June 2010 by Or Fooks and Assaf Zeira, HIKARI Laboratories operates with 1–10 employees. The company focuses on developing and distributing advanced skincare products for the professional cosmetic market, leveraging scientific collaborations to create innovative anti-aging solutions.
Business overview
HIKARI Laboratories develops, manufactures, and distributes skincare products for the professional cosmetic market. The company's core technology involves innovative patent-based developments in longevity, created in collaboration with scientists from the Hebrew University of Jerusalem. HIKARI Laboratories aims to provide real treatment for aging itself, rather than just addressing symptoms. A key focus is Mesotherapy, featuring Meso-Cocktails formulated for use with devices that increase skin permeability, such as Electroporation, Laser, Ultrasound, and Micro-needling devices. The company serves the health tech and life sciences sectors, specifically within cosmetic materials, targeting both professional and consumer markets across various global regions including Israel, Italy, and the United Kingdom.
Company Intelligence Q&A
- What is HIKARI Laboratories' primary focus?
- HIKARI Laboratories primarily focuses on developing, manufacturing, and distributing advanced skincare products designed for the professional cosmetic market, with an emphasis on anti-aging solutions.
- When was HIKARI Laboratories founded?
- HIKARI Laboratories was founded in June 2010.
- Who are the founders of HIKARI Laboratories?
- HIKARI Laboratories was founded by Or Fooks and Assaf Zeira.
- What kind of products does HIKARI Laboratories offer?
- HIKARI Laboratories offers products such as Meso-Rollers, Meso-Cocktails, and Meso-Pens, which are designed for anti-aging and skin treatment applications within the cosmetic industry.
- In which geographic markets does HIKARI Laboratories operate?
- HIKARI Laboratories operates in several geographic markets, including Israel, Estonia, Ukraine, Italy, Russia, Lithuania, the United Kingdom, Latvia, and China.